Human BTLA (31-150) (M105V, G138S, V148M) Protein, His Tag (MALS verified) | BTA-H52H5-50ug

Human BTLA (31-150) (M105V, G138S, V148M) Protein, His Tag (MALS verified) | BTA-H52H5-50ug| Gentaur Distribution US, UK & Europe

B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.

Source: Human BTLA (31-150) (M105V, G138S, V148M), His Tag (BTA-H52H5) is expressed from human 293 cells (HEK293). It contains AA Lys 31 - Ser 150 (Accession # AAP44003.1 (M105V, G138S, V148M) ).

Format: Powder.

Tag: C-10×His.

Expression System: HEK293.

Expression Region: Lys 31 - Ser 150.

Conjugate: Unconjugated.

Molecular Weight: 15.8 kDa.

Characteristics: This protein carries a polyhistidine tag at the C-terminus. The protein has a calculated MW of 15.8 kDa. The protein migrates as 27-33 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Purity: 90%.

Buffer: PBS, pH7.4.

Storage Conditions: -20℃.

Shipping Conditions: RT